Metformin HCL 1000MG Prolonged Release Tablets IP – Matulon 1000 SR Tablets

Matulon 1000 SR Tablets – Trusted First-Line Therapy, with Prolonged Action.

Matulon 1000 SR Tablets – Metformin HCL 1000MG Prolonged Release Tablets IP belongs to a group of anti-diabetic medicines called biguanides, which is the first-line therapy often fails to maintain adequate glycemic level and helps to prevent hepatic glucogenesis and glycogenolysis, which increases liver and peripheral tissue sensitivity to glucose and lowers Hb1Ac levels.
Its sustained-release formulation ensures gradual absorption, reducing peak plasma levels and minimizing gastrointestinal discomfort.
It is widely used as a cornerstone therapy for type 2 diabetes and is beneficial in managing metabolic syndrome and insulin resistance.

Key Benefits of Metformin HCL 1000MG Prolonged Release Tablets IP – Matulon 1000 SR Tablets
✅ Prolonged effect with Better Tolerability: Slow and steady release of metformin ensures fewer gastrointestinal side effects like nausea and bloating, improving patient adherence.
✅ First-Line Therapy for Type 2 Diabetes: Proven efficacy in glycemic control, weight neutrality, and insulin sensitivity improvement makes it a gold-standard treatment.
✅ Cardiovascular and Metabolic Benefits: Reduces HbA1c levels, supports weight management, and offers potential cardiovascular protective effects.

Recommended by Specialists:
👨‍⚕️ Endocrinologists: Often used as first-line therapy or in combination with other antidiabetics, for managing type 2 diabetes, especially in overweight or insulin-resistant patients.
👨‍⚕️ Diabetologists: For long-term glycemic control, especially when fasting and postprandial sugar levels are elevated.
👨‍⚕️ General Physicians: For routine management of type 2 diabetes and prediabetes, especially in patients at risk of cardiovascular complications.

Indications:
✅ Type-2 diabetes mellitus
✅ Pre-diabetes Management
✅ Polycystic Ovary Syndrome (PCOS)
✅ Metabolic Syndrome